All In Biotech

Drug Trial Radar · NCT02633813

BE Study of Naftifine HCL

A Randomized, Prospective Multicenter, Double Blind, Parallel Assignment Placebo Controlled BE Study Of Naftifine Hydrochloride 2% Topical Cream With Naftin® In Patients With Tinea Pedis Using Clinical Endpoints

Last checked: Nov 20, 2026Latest source record: May 11, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 693 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

693

Actual

Start

Mar 2015

Primary completion

Nov 2015

Study completion Dec 2015

Sponsor

Lead sponsor
Genzum Life SciencesIndustry
Sponsor type
Industry
First posted
Dec 17, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The current study was randomized, double blind, placebo-controlled, prospective, multicenter, comparative therapeutic equivalence study. The study duration for each patient was 6 weeks: Following were the visit details. V1-Baseline and Randomization Visit (Day 1). V2- End of therapy visit (at the end of week 2 + 2 days). V3- Follow up visit (at the end of week 4 + 2 days). V4 - Test of cure visit ( at the end of week 6 + 4 days).

Conditions

  • Tinea Pedis

Interventions

  • Naftifine hydrochloride 2%Drug

    Topical application for two weeks

  • PlaceboDrug

    Topical application for two weeks

  • Naftin® 2% (Naftifine hydrochloride 2%)Drug

    Topical application for two weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mycological cure and clinical cure for a single target lesion for Trichyphyton rubrumTime frame: week 6 + 4 days

Locations

14 sites in 2 countries. Site status is shown where the registry gives one.

  • Moore Clinical Research Inc

    Brandon, Florida

  • Savin Medical Group Research

    Miami, Florida

  • International Dermatology Research, Inc,

    Miami, Florida

  • FXM Research Corp

    Miami, Florida

  • FXM Research Miramar

    Miramar, Florida

  • South Tampa, MOORE Clinical Research, Inc.

    Tampa, Florida

  • North Tampa MOORE Clinical Research, Inc.

    Tampa, Florida

  • Medi Search

    Saint Joseph, Missouri

  • Bellaire Dermatology Associates

    Bellaire, Texas

  • Research Across America

    Dallas, Texas

  • Family Practise

    Mesquite, Texas

  • Research Across America

    Plano, Texas

  • Instituto Dermatológico y Cirugía de Piel

    Santo Domingo, San Cristóbal, Dominican Republic

  • Instituto Dermatológico

    Barrio Maria Auxiliadora, Santo Domingo Province, Dominican Republic

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.